Global News

Incyte, Genentech ink clinical trial agreement for cancer immunotherapies

Thursday, July 31, 2014 12:33 PM

Incyte has entered into a clinical trial agreement with Genentech to evaluate the safety, tolerability and preliminary efficacy of Incyte's oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, in combination with Genentech's PD-L1 immune checkpoint inhibitor, MPDL3280A, in patients with non-small cell lung cancer (NSCLC).

More... »

WIRB Copernicus Group

Theraclone, Gilead Sciences ink HIV antibodies agreement

Thursday, July 31, 2014 12:31 PM

Theraclone Sciences, a therapeutic antibody discovery and development company, has entered into an agreement with Gilead Sciences, under which Gilead received an exclusive license to develop and commercialize products incorporating Theraclone's broadly neutralizing HIV-antibodies for therapeutic applications in HIV.

More... »

Amy Schulman joins Polaris Partners

Thursday, July 31, 2014 11:24 AM

Polaris Partners has hired biopharmaceutical executive Amy Schulman as a venture partner, based out of Boston, Mass. Schulman, who most recently was general counsel, executive vice president and business unit lead of Pfizer consumer healthcare, will apply decades of experience to the Polaris healthcare portfolio. She also will assume the role of CEO of Arsia Therapeutics, an early stage Polaris-backed company co-founded by Dr. Robert Langer and Polaris partner Alan Crane. 

More... »

Zealand Pharma, Boehringer Ingelheim collaborate on novel peptide medicines

Wednesday, July 30, 2014 12:43 PM

Zealand Pharma, specializing in the discovery, design and development of peptide medicines, and Boehringer Ingelheim have announced a new global R&D collaboration. The collaboration covers a novel therapeutic peptide project from Zealand’s portfolio of preclinical programs. The aim is to develop novel medicines for improved treatment of cardio-metabolic diseases. The target is undisclosed.

More... »

PCI to acquire Penn Pharma

Wednesday, July 30, 2014 12:42 PM

Packaging Coordinators (PCI) has reached a definitive agreement to acquire Penn Pharmaceutical Services.

More... »

Report: Global HIV prevention research down $50M in 2013

Wednesday, July 30, 2014 12:40 PM

According to HIV Vaccines and Microbicides: Resource Tracking Working Group, in 2013 the reported funding for HIV prevention R&D declined by $50 million (4%) compared to 2012, after moderate  increases during the past five years in most HIV prevention R&D research areas, resulting in a total of $1.26 billion.

More... »

Report: Increasing potential for in vitro diagnostics in drug development process

Wednesday, July 30, 2014 12:39 PM

Bionest Partners, a life science industry strategic consulting firm, has found an increased potential for in vitro diagnostics in the drug development process.

More... »

Cloud Pharmaceuticals receives $150,000 phase I grant from NSF SBIR

Wednesday, July 30, 2014 12:37 PM

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, has been awarded a phase I grant from the National Science Foundation Small Business Innovation Research (NSF SBIR) program. The grant is valued at $150,000.

More... »

BioFusionary to complete reverse takeover of Continuation Investments

Wednesday, July 30, 2014 12:30 PM

Colorado-based BioFusionary, a medical technology company focused on developing a proprietary electromagnetic induction platform with aesthetic and surgical applications, has entered into an agreement under which BioFusionary will merge with Australia-based Continuation Investments in an all-stock transaction.

More... »

Amgen to cut up to 3,000 jobs, most in U.S., close facilities

Wednesday, July 30, 2014 11:42 AM

Amgen has announced a restructuring plan to invest in continuing innovation and the launch of its new pipeline molecules, while improving cost structure.

More... »

CenterWatch Data Library



Browse by:


August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs